Lobbying

Transparency Loses in GOP Lawmakers' Private Retreat

In his State of the Union address this week, President Obama urged members of Congress to be more transparent about their interactions with lobbyists. Yet this same week, members of the House Republican Caucus will attend a retreat sponsored by the non-profit Congressional Institute, where they will mingle privately with lobbyists.

No

Oil, Tobacco Interests Fund Luxury Getaway for Republicans

Oil and tobacco companies and other businesses hoping to press their agenda in the California legislature picked up most of the tab for a gathering of about 25 Republican state legislators and a dozen of their aides at a luxurious beach resort in Santa Barbara, California.

No

Coal Lobby Eyes Illinois Subsidies

McGuireWoods Consulting, a Chicago-based PR and lobbying firm, has been hired by the FutureGen Alliance to lobby Illinois legislators to financially support FutureGen, a proposed coal-fired power station which would use the experimental Carbon Capt

No

Senate Health Reform Bill Benefits Big Pharma While Forsaking Cheaper Generic Drugs

Big pharmaceutical companies benefit from a provision in the Senate health care reform billDespite proclaiming a need to cut medical costs, the Senate health care reform bill contains a provision that will benefit large drug companies while hurting manufacturers of generic drugs. As it is now written, the bill will keep less-expensive generic drugs from entering the market for fully 12 years, far longer than the five to seven years President Barack Obama had advocated. The concession to Big Pharma companies, which manufacture expensive brand-name drugs, follows an $80 billion agreement made earlier this year between the White House and large drug makers like Merck and Pfizer, who promised to support President Obama's health reform plan, cut drug prices and pay additional taxes to help expand health insurance coverage over the next 10 years. Kathleen Jaeger, President and CEO of the Generic Pharmaceutical Association, said the health reform bill passed by the Senate " ... unfortunately, amounts to a treasure trove to brand drug companies who stand to make enormous profits from health care reform -- putting brand drug profits over patients ... With generics saving the health care system one billion dollars every three days, Congress should be looking at increasing, not decreasing, access to safe effective and affordable generic and biogeneric medicines."

No

Pages

Subscribe to Lobbying